Dyadic International Inc (DYAI) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.41 (-2.05%), Market cap $0.03B, 52-week low–high $0.68 ~ $1.30.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vacc
Financial statements, price targets, institutional (13F) holdings and related news for Dyadic International Inc are updated in real time on BlackAll Trade.
Dyadic International Inc trades at $0.41 (-2.05%). Real-time quotes and charts are available on BlackAll Trade.
Dyadic International Inc has a market cap of about $0.03B.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers D